HARP लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (9 Mar 2024 @ 02:30):

Stats
आज की मात्रा	6.40M
औसत मात्रा	1.13M
बाजार मूल्य	865.08M
EPS	$-0.460 ( Q3 \| 2023-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-15.04 (Sector) 42.63 (Industry) 24.32
ATR14	$0.377 (1.64%)

AADI -2.64%

ABCL 1.79%

ABCM 0.04%

ABEO -2.84%

ABIO -0.98%

ABOS 0.70%

ABSI 2.89%

ABUS -2.46%

ABVX -3.53%

ACAD -0.83%

ACER -17.95%

ACET -3.40%

ACGN 1.29%

ACHL -4.15%

ACHV -1.72%

ACIU -0.50%

ACLX -0.13%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.80%

ADGI 0.87%

ADIL 0.54%

ADMA -2.41%

ADPT -0.44%

ADTX -3.47%

ADVM -3.18%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.61%

AGIO -1.88%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.13%

AKRO -2.70%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.11%

ALEC -3.90%

ALGS -2.41%

ALKS -0.21%

ALLK -8.90%

ALLO -6.64%

ALLR -4.09%

ALNA 3.16%

ALNY 1.62%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.46%

ALVR -0.59%

ALXN 0.00%

ALXO -10.65%

ALZN 4.78%

AMRN 0.26%

AMTI -3.13%

ANAB 0.42%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.44%

ANPC -3.15%

APGE -0.96%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.22%

APLT -3.94%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.03%

ARDS -14.23%

ARDX -0.91%

ARGX -0.93%

ARNA 0.00%

ARPO -0.90%

ARQT -0.52%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.19%

ARWR -1.77%

ASLN -3.44%

ASMB -3.70%

ASND -0.91%

ATAI -1.48%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.98%

ATOS 3.86%

ATRA -2.89%

ATXI 1.93%

ATXS -0.89%

AUPH -0.99%

AURA -0.15%

AUTL -1.87%

AVBP -2.79%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -5.52%

AVTX -1.25%

AVXL -2.84%

AXLA 0.00%

AXSM -1.73%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.52%

BCAB 3.92%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.56%

BCTX 8.12%

BCTXW -21.88%

BCYC 0.55%

BDRX -5.90%

BDTX -0.85%

BEAM 0.08%

BFRA -2.91%

BGNE -2.19%

BIOR -3.40%

BIVI 0.56%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.81%

BMEA -9.64%

BMRN 0.34%

BNOX -2.22%

BNTC -2.11%

BNTX -1.21%

BOLD -8.15%

BOLT -0.18%

BPMC -1.22%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.38%

BTAI 24.58%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.90%

CADL -1.23%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -3.01%

CARA 0.85%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -7.00%

CCCC -5.26%

CCXI 0.00%

CDAK 0.00%

CDIO -3.09%

CDIOW 24.00%

CDMO -2.68%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.31%

CELC -3.82%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.78%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.74%

CGEN -3.31%

CGON -0.13%

CGTX -4.55%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 0.70%

CINGW 34.95%

CKPT -2.89%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD -2.90%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.23%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -41.20%

CNST 0.00%

CNTA -0.73%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.00%

CORT 2.30%

COYA -1.46%

CPRX -0.86%

CRBP -1.85%

CRBU -4.84%

CRDF -2.21%

CRGX 1.27%

CRIS -0.38%

CRNX -6.20%

CRSP 0.99%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.29%

CTNM -1.02%

CTXR 1.13%

CUE 3.53%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 9.84%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.04%

CYTO -2.73%

DARE 6.54%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 32.60%

DNLI -1.97%

DNTH -6.01%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 0.89%

DYAI 9.68%

EARS -1.77%

EDIT -2.51%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.19%

ELOX 7.69%

ELTX -0.88%

ELVN -4.52%

ELYM 0.77%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.44%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 6.35%

EVLO 0.00%

EWTX -0.03%

EXAI -0.76%

EXEL -0.27%

EYEG -0.69%

EYEN 1.54%

EYPT 0.00%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -17.00%

FBRX -0.04%

FDMT -4.59%

FENC -1.29%

FGEN -4.70%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.53%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.53%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.65%

GHRS -2.85%

GLMD -2.15%

GLPG -2.30%

GLSI 2.80%

GLTO -1.20%

GLUE -1.58%

GLYC -9.59%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 1.56%

GNPX 0.98%

GNTA 3.94%

GOSS -7.81%

GOVX 4.50%

GOVXW -49.04%

GPCR -6.86%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.14%

GRTX 0.00%

GTHX 0.23%

GUTS -4.85%

GXGXW 41.67%

GYRE -6.02%

HALO -0.77%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 1.10%

HRTX 1.97%

HSTO 0.00%

HUMA 1.12%

HUMAW -0.01%

IBRX -4.13%

ICCC 0.22%

ICPT 0.21%

ICU 16.67%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.50%

IFRX -2.66%

IGMS -0.11%

IKNA 0.60%

IKT 1.42%

IMAB -0.58%

IMCR -2.60%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -7.76%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.62%

INAB 0.59%

INBX 0.46%

INCY -0.89%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.65%

INO -1.82%

INSM -0.77%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.02%

IONS 0.02%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.35%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.04%

JANX -4.26%

JAZZ -0.54%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -2.16%

KDNY 0.22%

KMPH -0.34%

KNSA -2.95%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -1.83%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -6.34%

KRTX 0.03%

KRYS -0.89%

KTRA 17.05%

KTTA 8.16%

KTTAW 0.92%

KURA -1.81%

KYMR -2.26%

KYTX -3.55%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -0.89%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -4.07%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -8.51%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -5.03%

LPTX -1.65%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 0.25%

LUMO -1.32%

LVTX 0.00%

LXEO -4.83%

LXRX -2.06%

LYEL -35.47%

LYRA 2.71%

MACK 0.10%

MBIO -9.02%

MBRX -1.72%

MCRB 1.36%

MDGL -2.64%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.61%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -6.11%

MNKD -0.95%

MNMD 0.28%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.70%

MREO -4.14%

MRKR 2.68%

MRNA -4.95%

MRNS -4.03%

MRSN -2.62%

MRTX -0.17%

MRUS 0.26%

MRVI -1.97%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.40%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.27%

NKTX -4.57%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.74%

NMTR -42.97%

NOVN -24.84%

NRBO 12.16%

NRIX -0.63%

NRSN -3.63%

NRSNW 0.00%

NRXP -5.39%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.17%

NTRBW -31.07%

NUVL -2.13%

NVAX -1.57%

NVCT 3.94%

NVIV -34.28%

NXTC -2.95%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -3.21%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -1.83%

OCUP 1.63%

ODT -4.27%

OKYO 1.51%

OLMA -5.63%

OMER -0.90%

OMGA 6.25%

ONCO 7.71%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 1.03%

ORGS -4.53%

ORIC -3.42%

ORMP 15.18%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.31%

PBLA -7.50%

PBM -8.30%

PBYI 1.69%

PCSA 0.00%

PCVX -0.23%

PDSB -0.80%

PEPG 1.70%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.26%

PHIO -3.62%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT 0.28%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.89%

PRQR -0.01%

PRTA -2.34%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.17%

PTCT -0.16%

PTE -0.82%

PTGX -1.64%

PTIXW -49.04%

PULM 2.62%

PXMD 0.00%

PYPD 0.07%

PYXS 3.59%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.93%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -3.22%

RARE 1.22%

RCKT -8.08%

REGN -0.74%

RENB -3.42%

REPL -3.00%

RETA 0.02%

REUN -0.89%

REVB -1.42%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.19%

RIGL -3.29%

RLAY -4.60%

RLMD 0.33%

RLYB -0.34%

RNA -0.36%

RNAC -5.65%

RNAZ -0.95%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.30%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.15%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.02%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.41%

RYTM -6.25%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -4.24%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.25%

SCPS 0.00%

SEEL -4.09%

SEER -0.44%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.01%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -4.73%

SLGL 4.00%

SLN -4.21%

SLNO -2.82%

SLRX 5.91%

SLS -2.99%

SMMT -2.62%

SNDX 0.72%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -34.00%

SRPT -1.16%

SRRA 0.00%

SRRK -2.35%

SRZN -2.45%

STAB 0.00%

STOK -5.05%

STRO -2.68%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -2.89%

SWTX 0.33%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -8.06%

TARS 0.08%

TBPH 0.48%

TCBP 2.74%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.67%

TECH -0.07%

TENX -1.27%

TERN -6.47%

TFFP -3.05%

TGTX -2.87%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.27%

TNXP -5.59%

TNYA -8.93%

TPST 2.42%

TRDA -3.86%

TRVI 1.15%

TRVN 5.02%

TSHA -23.94%

TSVT -3.06%

TTNP -9.27%

TVTX 0.63%

TYRA -8.19%

UBX -2.12%

UNCY -3.40%

URGN -1.94%

UTHR -0.28%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL 0.29%

VCNX 10.35%

VCYT -1.23%

VERA -2.80%

VERU 0.73%

VERV -2.58%

VIGL 4.27%

VINC 1.62%

VIR 0.65%

VIRI -1.61%

VIRX 2.38%

VKTX -1.05%

VLON -13.04%

VNDA -2.36%

VOR -2.41%

VRCA 0.28%

VRDN -4.00%

VRNA -1.20%

VRPX 0.38%

VRTX 0.10%

VSTM -3.40%

VTGN -0.46%

VTVT -2.97%

VTYX -0.21%

VXRT -2.26%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT 1.46%

XCUR 3.61%

XENE -3.11%

XERS 2.38%

XFOR 3.11%

XLO 4.43%

XLRN 0.00%

XNCR 0.05%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.24%

ZNTL -2.98%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-03-11	New Leaf Biopharma Opportunities Ii, L.p.	Sell	395 783	Common Stock
2024-03-11	New Leaf Biopharma Opportunities Ii, L.p.	Sell	10 000	8.000% Series A Redeemable Preferred Stock
2024-03-11	New Leaf Biopharma Opportunities Ii, L.p.	Sell	299 430	Common Stock Warrant (Right to Buy)
2024-03-11	New Leaf Biopharma Opportunities Ii, L.p.	Sell	85 750	Common Stock Warrant (Right to Buy)
2024-03-11	Silvernail Lauren P	Sell	5 000	Common Stock

INSIDER POWER
76.25
Last 96 transactions
Buy: 30 137 007 \| Sell: 5 308 481

मात्रा सहसंबंध

लंबा: 0.48 (neutral)

छोटा: 0.40 (neutral)

Signal:(82.718) Neutral

Harpoon Therapeutics Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Harpoon Therapeutics Inc सहसंबंध - मुद्रा/वस्त्र

0.51
( weak )

0.07
( neutral )

0.81
( strong )

0.46
( neutral )

-0.06
( neutral )

-0.86
( strong negative )

Harpoon Therapeutics Inc वित्तीय

Annual	2022
राजस्व:	$31.92M
सकल लाभ:	$28.82M (90.30 %)
EPS:	$-20.24

FY	2022
राजस्व:	$31.92M
सकल लाभ:	$28.82M (90.30 %)
EPS:	$-20.24

FY	2021
राजस्व:	$23.65M
सकल लाभ:	$23.65M (100.00 %)
EPS:	$-3.62

FY	2020
राजस्व:	$17.44M
सकल लाभ:	$17.44M (100.00 %)
EPS:	$-1.990

Financial Reports:

No articles found.

Harpoon Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Harpoon Therapeutics Inc

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian and pancreatic cancer, and other mesothelin-expressing tumors. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.